Our findings indicate that while SPARC's N-terminus domain inhibits tumor growth, the follistatin-like (FS-) domain alone may have growth-promoting properties, as xenografts overexpressing recombinant proteins of this fragment had significantly shorter doubling times than control xenografts. Here, FST is linked to neoplasm.